Axerion Therapeutics

We are developing therapeutics for the management and treatment of Alzheimer's Disease and Chronic Spinal Cord Injury with IP licensed from Yale.,

  • Stage Concept Only
  • Industry Biotechnology
  • Location New Haven, CT, USA
  • Currency USD
  • Employees 7
  • Website axeriontherapeutics.com

Company Summary

Team

  • Sylvia McBrinn
    President and CEO

  • Sean Cassidy
    V P and CFO

  • George Maynard
    VP Medicinal Chemistry

  • Eric Frieden
    VP Process Science

  • Sean Cassidy

Advisors

  • Sills Cummis
    Lawyer
    Unconfirmed
    PriceWaterhouseCoopers
    Accountant
    Unconfirmed

Previous Investors

  • Connecticut Innovations
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free